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Both population-based and family-based designs are commonly used in genetic association studies to identify rare
variants that underlie complex diseases. For any type of study design, the statistical power will be improved if rare
variants can be enriched in the samples. Family-based designs, with ascertainment based on phenotype, may
enrich the sample for causal rare variants and thus can be more powerful than population-based designs.
Therefore, it is important to develop family-based statistical methods that can account for ascertainment. In this
paper, we develop a novel statistical method for rare-variant association studies in general pedigrees for
quantitative traits. This method uses a retrospective view that treats the traits as fixed and the genotypes as
random, which allows us to account for complex and undefined ascertainment of families. We then apply the
newly developed method to the Genetic Analysis Workshop 19 data set and compare the power of the new
method with two other methods for general pedigrees. The results show that the newly proposed method
increases power in most of the cases we consider, more than the other two methods.Background
There is increasing interest in detecting associations
between rare variants and complex traits. Although stat-
istical methods to detect common variant associations
are well developed, these variant-by-variant methods
may not be optimal for detecting associations with rare
variants as a result of allelic heterogeneity as well as the
extreme rarity of individual variants [1]. Recently, several
statistical methods for detecting associations of rare vari-
ants were developed for population-based designs, includ-
ing the cohort allelic sums test [2], the combined
multivariate and collapsing method [1], the weighted sum
statistic [3], the variable minor allele frequency threshold
method [4], the adaptive sum test [5], the step-up method
[6], the sequence kernel association test [7], and the test
for optimally weighted combination of variants [8].
Meanwhile, quite a few statistical methods for rare-
variant association studies have been developed for
family-based designs. For any type of study design, the* Correspondence: qsha@mtu.edu
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enriched in the samples. If one parent has a copy of a
rare allele, half of the offspring are expected to carry it,
and, hence, variants that are rare in the general popula-
tion could be very common in certain families [9].
Therefore, family-based designs may play an important
role in rare-variant association studies. Because of the
importance of family-based designs in rare-variant asso-
ciation studies, several family-based rare-variant associ-
ation methods for quantitative traits [10–12] and for
qualitative traits [13–15] have been developed. However,
most of these methods were developed under the
assumption of random ascertainment and family-based
designs with random ascertainment may not yield en-
richment of rare variants. To analyze the sequencing
data in general pedigrees provided by Genetic Analysis
Workshop 19 (GAW19), we proposed a novel method
to test rare-variant association in general pedigrees for
quantitative traits. Applying the proposed method to the
GAW19 data set, we compared the power of the pro-
posed method with that of two popular methods for
family-based designs.le is distributed under the terms of the Creative Commons Attribution 4.0
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Consider a sample of n pedigrees with ni members in
the ith pedigree and a genomic region with M variants.
Let yij and gij = (gij1,…, gijM)
T denote the trait value and
genotypes of the M variants in the genomic region for
the jth individual in the ith pedigree. Let xij = ∑m = 1
M wmgijm
denote the weighted combination of genotypes at the M
variants, where w = (w1,… ,wM)
T is a weight function.
For given genotypes, we assume that yij ∼N(a + xijβ, σ
2).
Using the notation gi ¼ gi1;…; gini
 T
, the retrospective

















































represents the summation of all possible ge-
notypes. Based on RL, the score test statistic for testing
the null hypothesis H0 : β = 0 is given by










, V =wTΣw∑ni =
1yi












Φi is twice the kinship coefficient of the i
th pedigree, and
Σ = cov(g11, g11) is the covariance matrix of the multiple
variant genotype of one individual. Σ can be






















gij . It is
worth pointing out that Tscore is equivalent to the
quantitative version of the retrospective likelihood
score statistic proposed by Schaid et al [16].
Because rare variants are essentially independent,
following Pan [17] and Sha et al [8], we replace Σ^ by
Σ^0 ¼ diag Σ^
 
. Then, the score test statistic Tscore becomes

















. As a function of
w, T0(w) reaches its maximum when w ¼ Σ^ 0−1u and the




yTi Φiyi . Wedefine the statistic of optimally weighted score test
(OW-score) as

















where σmm is the (m, m)
th element of Σ^ 0 and um is the m
th
element of u. Under the null hypothesis, TOW-score is
asymptotically distributed as a mixture of independent χ2
statistics [18, 19]. Alternatively, the distribution of TOW-
score can be approximated by a Satterwaite approximation
for the distribution of quadratic forms [7, 20, 21] or a
scaled χ2 distribution [16]. We propose to approximate
the distribution of TOW-score by a scaled χ
2 distribution
with the scale δ and degrees of freedom d estimated by
the expectation and variance of TOW-score. Note that u ∼
N(0, Σ∑i = 1
n yi




and σ^ 2T ¼ var^ TOW−scoreð Þ ¼ 2trace Σ^ Σ^ 0−1 Σ^ Σ^0−1
 
.
Then, the scale δ is estimated as δ^ ¼ σ^ 2T= 2μ^Tð Þ and the
degree of freedom d is estimated as d^ ¼ 2μ^2T=σ^ 2T
We compare the performance of our OW-score with
(a) WS-score, the score test given by equation (1) with
weight given by Madsen and Browning [3] and (b) famS-
KAT, family-based sequence kernel association test given
by Chen et al [11].
Results
We applied our proposed method as well as the WS-
score test and famSKAT to the simulated data from
GAW19. All tests were conducted on 849 individuals,
from 20 pedigrees, that had no missing genotypes or
phenotypes. Sex, age, blood pressure medication status,
and smoking status were considered as covariates in this
study. We were aware of the underlying simulation
model.
There are two related phenotypes, systolic blood pres-
sure (SBP) and diastolic blood pressure (DBP), at three
time points. We considered the average of DBP at three
time points as the phenotype of interest in our analysis.
We compared the power of the three tests (OW-score,
WS-score, and famSKAT) to detect association between
each of the top 14 genes that influence the phenotype of
interest. We used the variants between the first func-
tional single nucleotide polymorphism (SNP) and the
last functional SNP in each gene in our analysis. We did
not consider CABP2 because the power of the three
tests are essentially the same due to only one variant in
this gene. To adjust the effects of the covariates on the
phenotype of interest, we first applied a linear model by
regressing the phenotype of interest on the covariates:
sex, the average of age, the average of blood pressure
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The power comparisons based on the 200 replicated
data sets are given in Table 1. Significance level is
assessed at 5 %. This table shows that the OW-score test
identified three genes with power greater than 40 %,
famSKAT identified 1 gene with power greater than
40 %, and the WS-score test could not identify any genes
with power greater than 40 %. OW-score and famSKAT
have different power mainly because they use different
weights. Let wm and Wm denote the weights, rescaled to
the interval (0, 1), of the OW-score test and famSKAT
for the mth variant. Then, wm >Wm when minor allele
frequency (MAF) is less than 0.01; wm ≤Wm when MAF
is in the interval (0.01, 0.05); wm >Wm when MAF is
greater than 0.05. The OW-score test has much higher
power than famSKAT for RAI1 and REPIN1 because
none of the MAFs of the causal variants in RAI1 and
REPIN1 are in the interval (0.01, 0.05).
We also evaluated the type I error rate of the proposed
OW-score test. To evaluate the type I error, we used
1000 blocks (100 variants in each block) from chromo-
some 5 that are far from causal variants. In each block,
we applied the OW-score test to each of the 200 repli-
cates to test association between genotypes and the
phenotype of interest. We obtained 1 p value for each
replicate and each block. The type I errors of the pro-
posed test were 0.04887, 0.00921, and 0.00131 at signifi-
cance levels of 0.05, 0.01, and 0.001, respectively. We
also considered the average of SBP at three time points
as the phenotype of interest, which yielded similar
results.Table 1 Power comparisons of the 3 tests using the average
of DBP at 3 time points as phenotypes (significance level is
assessed at 5 %)
Genes TOW-score TWS-score FamSKAT
CGN 0.135 0 0.035
FLT3 0.005 0 0.08
LEPR 0.05 0.015 0.065
MAP4 0.175 0.185 0.425
MTRR 0.465 0.005 0.06
NRF1 0 0.005 0.035
PTTG1IP 0.02 0.145 0.06
RAI1 0.845 0.005 0.155
REPIN1 0.915 0.05 0.085
SLC35E2 0.005 0 0.05
TNN 0 0 0.035
ZFP37 0 0.005 0.005
ZNF443 0.01 0.015 0.195
ZNF544 0.005 0.015 0.06
Notes: the powers greater than 40 % are in boldDiscussion
Next-generation sequencing technologies make directly
testing rare variant association possible. However, the
development of powerful statistical methods for rare-
variant association studies is still underway. In this article,
we proposed a novel statistical method for rare-variant as-
sociation studies based on general pedigrees for quantita-
tive traits. The application to the GAW19 data set showed
that the proposed method has correct type I error rate
and is more powerful than the other two methods against
which our method was compared.
We described our method for quantitative traits. For
qualitative traits, we can derive a score test similar to
that given by equation (1). However, the performance of
the proposed method for qualitative traits requires further
investigation. Like many statistical methods for rare vari-
ant association studies, the proposed method can consider
phenotype measurement at only one time point. Statistical
methods based on sequence data have been developed for
unrelated individuals that have phenotype measurements
at multiple time points [22]. From a statistical standpoint,
modeling using longitudinal phenotypes is more inform-
ative than that using phenotypes at a single time point
and thus can increase the power of an association test
[22, 23]. Our future work includes extension of the
proposed method to longitudinal phenotypes.
Conclusions
In this article, we developed a novel statistical method
for rare variant association studies in general pedigrees
(randomly ascertained pedigrees or ascertained pedigrees).
Application to the GAW19 data set showed that the newly
proposed method is more powerful than the other two
methods in most of the cases. Our new method uses a
retrospective view, which allows us to account for complex
and undefined ascertainment of families. The GAW19 data
is based on randomly ascertained pedigrees. Results of ap-
plying our method to GAW19 data showed that the pro-
posed method has correct type I error based on random
ascertainment. When random ascertainment is violated
and ascertainment is based on trait values, the proposed
method is expected to have correct type I error. If pedigrees
are ascertained because of extreme trait values, the pro-
posed method is expected to have higher power than
methods based on randomly ascertained pedigrees.
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